Ocumetics Announces December 20, 2023 Webinar regarding Successful Completion of Animal Study

Ocumetics Announces December 20, 2023 Webinar regarding Successful Completion of Animal Study

(TheNewswire)

Ocumetics Technology Corp.

Ocumetics Technology Corp. (" Ocumetics ") ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) a pioneer in the field of ophthalmic innovation, announces a webinar to discuss the successful completion of its biocompatibility animal study and its upcoming first-in-human study, anticipated to commence in Q1 2024 in the Dominican Republic

Dean Burns, CEO of Ocumetics and 27-year Alcon veteran, will lead the presentation.


Click Image To View Full Size

Join the webinar to:

  • Learn more about the significance of the biocompatibility animal study;

  • Learn more about the upcoming first-in-human study; and

  • Ask questions regarding the Ocumetics Accommodating Lens and the company's plans.

Details are as follows:

Date:         December 20, 2023

Time:         18:00 EST

RSVP: https://ocumetics.com/webinar-december-20-2023/

About Ocumetics

Ocumetics Technology Corp. ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), headquartered in Calgary, Alberta, Canada, is an innovator in the field of ophthalmic technology, dedicated to developing and commercializing advanced vision correction solutions that enhance the quality of life for individuals worldwide.

Ocumetics is in the preclinical study stage of a game-changing technology for the ophthalmic industry.  In its pursuit of a next generation interocular lens solution, Ocumetics has developed the Ocumetics Accommodating Lens, an expandable intraocular lens that fits within the natural lens compartment of the eye potentially to eliminate the need for corrective lenses.  It is designed to allow the eye's natural muscle activity to seamlessly shift focus from distance to intermediate to near.

FOR FURTHER INFORMATION, PLEASE CONTACT:

Dean Burns
President and CEO
(817) 874-7564

Dayton Marks
Director
(778) 347-2500

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2023 TheNewswire - All rights reserved.

News Provided by TheNewsWire via QuoteMedia

OTC:CA
Ocumetics Technology

Ocumetics Technology Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
Ocumetics Technology

Ocumetics Technology


Keep reading...Show less
Ocumetics Technology Corp  To Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar

Ocumetics Technology Corp To Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar

(TheNewswire)

Ocumetics Technology Corp.

Calgary, Alberta TheNewswire - February 29, 2024 - Ocumetics Technology Corp. ("Ocumetics") (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO), is pleased to invite investors and other interested parties to attend an upcoming interview with Market Radius Research.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Ocumetics Announces Extension of Private Placement

Ocumetics Announces Extension of Private Placement

(TheNewswire)

Ocumetics Technology Corp.

Calgary, Alberta TheNewswire - December 21, 2023 - Ocumetics Technology Corp. (" Ocumetics " or the " Corporation ") (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) is pleased to announce that the TSX Venture Exchange has granted a 15-day extension to close the Corporation's non-brokered private placement announced on November 15, 2023. The new closing deadline for the private placement is January 15, 2024.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Ocumetics Announces Successful Completion of Animal Study Q1 2024 First in Human Study Planned

Ocumetics Announces Successful Completion of Animal Study Q1 2024 First in Human Study Planned

(TheNewswire)

Ocumetics Technology Corp.

Calgary, Alberta TheNewswire - December 7, 2023 - Ocumetics Technology Corp. (" Ocumetics ") ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO), a pioneer in the field of ophthalmic innovation, proudly confirms the successful completion of its biocompatibility animal study, in preparation for its first-in-human study, anticipated to commence in Q1 2024 in the Dominican Republic.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study

Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study

(TheNewswire)

Ocumetics Technology Corp.

Calgary, Alberta September 18, 2023. Ocumetics Technology Corp. (" Ocumetics ") ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO), a pioneer in in the field of ophthalmic innovation, proudly confirms a remarkable achievement in the optimization of its vision correction technology - the Ocumetics Accommodating Lens. Through rigorous research and development efforts over the past two years, Ocumetics has modified its lens design five times, ultimately arriving at its groundbreaking final lens configuration version 10.5. Lens version 10.5 has been tested in vitro and in an animal model, and will be used in Ocumetics' upcoming human clinical trials.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors

Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors

(TheNewswire)

Ocumetics Technology Corp.

Calgary, Alberta TheNewswire - September 1, 2023 - Ocumetics Technology Corp. (" Ocumetics " or the " Corporation ") ( TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) a pioneer in advanced eye care solutions, is pleased to announce the appointment of Dr. Doyle Stulting and Dr. Bart McRoberts to its Board of Directors. With their unparalleled expertise in ophthalmology and vision research, Drs. Stulting and McRoberts bring a wealth of knowledge that will help drive Ocumetics' innovation and commitment to improving eye care globally.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Aether Global Announces Loan Agreement

Aether Global Announces Loan Agreement

(TheNewswire)

Aether Global Innovations Corp.

Vancouver, B.C. TheNewswire - May 3, 2024 Aether Global Innovations Corp. (CSE:AETH) (OTC:AETHF) (Frankfurt:4XA) (WKN#A2N8RH), a leader in drone management and automation, announces it has entered into a loan agreement (the "Loan Agreement") dated April 30, 2024 with an arm's length lender for the principal amount of $30,000.00 (the "Loan").

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
ARway.ai The Augmented Reality Experience Platform Signs Multiple New Navigation Deals With Global Accounts Riyad Bank & A Museum in the Heart of Washington, D.C.

ARway.ai The Augmented Reality Experience Platform Signs Multiple New Navigation Deals With Global Accounts Riyad Bank & A Museum in the Heart of Washington, D.C.

Demand For Augmented Reality Navigation is Accelerating

ARway.ai ("ARway" or the "Company") (CSE:ARWY)(OTCQB:ARWYF)(FSE:E65) is an AI powered Augmented Reality Experience platform with a disruptive no-code, no beacon spatial computing solution enabled by visual marker tracking with centimeter precision is pleased to announce two new deals with new partners

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Nextech3D.ai Achieves Milestone with 3D AI Modeling Profit Margins Hitting 80% in Q2 2024 Up From 30% in 2023

Nextech3D.ai Achieves Milestone with 3D AI Modeling Profit Margins Hitting 80% in Q2 2024 Up From 30% in 2023

Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a patented 2D-3D Generative AI-Powered 3D model supplier for Amazon, Miele, P&G, Kohls, Wesfarmers Group "Bunnings" (Australia's largest listed company) and other major e-commerce retailers is excited to announce a major milestone in its 3D modeling business for ecommerce by hitting 80% gross profit in Q2, 2024 which is up 166% from 30% in 2023. This milestone achievement is only possible through the company's investment in AI and its pivot to Hyderabad India in Q3, 2023

The company believes that it can become profitable in 2024 by scaling revenue with 80% profit margins while operating expenses are going down due to its investment in its patented AI. The strategic shift to Hyderabad India aligns perfectly with Nextech3D.ai's commitment to delivering top-tier 3D modeling and augmented reality solutions while maintaining a keen eye on profitability and fiscal responsibility for its valued shareholders.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Closeup of Amazon logo on the Amazon building in Palo Alto, California.

Amazon Exceeds Expectations with Q1 Earnings

Amazon (NASDAQ:AMZN) exceeded experts' expectations with its Q1 results, which it released on Tuesday (April 30). The tech giant reported net income of US$10.4 billion, a 235 percent increase over Q1 2023's US$3.1 billion.

This works out to US$0.98 per diluted share, much higher than analysts’ average estimate of US$0.83 per share.

The company’s net sales totaled US$143.3 billion during Q1, a 13 percent increase compared to the year-ago period. North American sales accounted for the largest portion at US$86.3 billion, up 12 percent year-on-year.

Keep reading...Show less
XReality Group

Quarterly Activities Report and Appendix 4C - 31 Mar 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following Quarterly Activities Report and Appendix 4C for the quarter ending 31st March 2024 together with an Operational Update.

Keep reading...Show less
Nextech3D.ai Reports Fiscal Year 2023 and Fourth Quarter 2023 Audited Financial Results

Nextech3D.ai Reports Fiscal Year 2023 and Fourth Quarter 2023 Audited Financial Results

2023 Annual revenue growth of + 56%

2023 Annual revenue of $5 million

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Ocumetics Technology

Ocumetics Technology Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Latest Press Releases

Related News

×